Add this topic to your myFT Digest for news straight to your inbox
Groups say continuation of a scheme aimed at limiting NHS’s medicines bill will reduce or end their British operations
South Korean group targets $1.3bn in annual sales in markets including Europe and US
Foreign investors make more than $6bn in bets against stocks since restrictions removed
Seoul to allow practice for large-cap stocks amid growing power for retail investors
South Korean biotech stocks have been a favourite of retail investors even before the pandemic
Stock exchange to monitor company’s efforts to boost management transparency for 3 years
Offshore demand sends share price of South Korean drugs group up 55% in 2 weeks
New kind of copycat drugs pose threat to big pharma
South Korean maker of biosimilar drugs targets valuation of at least $8bn
Seoul government pinpoints drug industry as next source of innovation
Cut-price versions of blockbuster anti-inflammatory drugs go on sale
International Edition